Arndt Vogel· @ArndtVogel · X·· 2 天前评分70
正文 · 机器翻译
安贝尼单抗联合化疗用于既往治疗过的HER2阳性GC/GEJC：KC-WISE的OS更新分析 🇨🇳
#ESMO26 #ESMOAmbassadors
👉 ORR：56% vs 13%
👉 mOS：19.6 vs 9.7个月
👉 未观察到意外安全性信号
🧐 支持HER2的序贯靶向
@myESMO @ASCO
921 浏览 · 18 赞 · 7 转发 · 0 回复
会议摘要
LBA15按 Proffered paper 2: Breast cancer, early and advanced stage 对上
Anbenitamab plus albumin-bound docetaxel in patients (pts) with HER2-positive advanced breast cancer (BC): A randomized phase III study
https://esmocongress.esmo.orgLBA80按 Rapid oral 1: Gastrointestinal tumour, upper digestive 对上
Anbenitamab plus chemotherapy for previously treated HER2-positive gastric or gastroesophageal carcinomas (GC/GEJC): Updated overall survival (OS) analysis of KC-WISE
https://esmocongress.esmo.org来源：Arndt Vogel · x.com